Perpetua Medical AB (publ) (STO:PERP.B)
Sweden · Delayed Price · Currency is SEK 3.340
-0.090 (-2.62%)
Aug 14, 2026, 4:07 PM CET
Perpetua Medical AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1.7 | 2.45 | -2.47 | -18.28 | -19.16 | -13.71 |
Depreciation & Amortization | 2.5 | 2.5 | 0.32 | 0.18 | 0.39 | 0.38 |
Loss (Gain) From Sale of Assets | -9.46 | -9.46 | -6.33 | 0.23 | - | - |
Asset Writedown & Restructuring Costs | - | - | - | 0.15 | 0.13 | 0.02 |
Other Operating Activities | -1.64 | -1.68 | 1.67 | -0.13 | 0.18 | 0.01 |
Change in Accounts Receivable | 1.25 | 0.27 | 0.4 | 0.93 | -0.59 | -1.84 |
Change in Inventory | 0.02 | -0.1 | 0.7 | 0.09 | -0.42 | -0.24 |
Change in Accounts Payable | -0.14 | 0.09 | -0.16 | -0.3 | -0.29 | 0.9 |
Change in Other Net Operating Assets | 0.35 | 0.47 | -1.15 | 0.72 | 0.59 | -0.87 |
Operating Cash Flow | -5.43 | -5.46 | -7.03 | -16.41 | -19.19 | -15.34 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -1.07 | -1.07 | - | - | -0.46 | -0.5 |
Sale of Property, Plant & Equipment | - | - | - | 0.1 | - | - |
Cash Acquisitions | -8.44 | -8.44 | -3.56 | - | - | - |
Sale (Purchase) of Intangibles | 0.18 | 1.26 | 6.97 | -0.62 | -1.05 | -0.61 |
Investment in Securities | -0 | -0 | 0.35 | -0.35 | 0.5 | -0.18 |
Other Investing Activities | - | - | 1.01 | - | - | - |
Investing Cash Flow | -9.33 | -8.25 | 4.78 | -0.87 | -1.01 | -1.3 |
Long-Term Debt Issued | - | 8.77 | 4 | - | - | - |
Long-Term Debt Repaid | - | -0.13 | -0.06 | -0.33 | -0.36 | -0.33 |
Net Debt Issued (Repaid) | 8.6 | 8.64 | 3.94 | -0.33 | -0.36 | -0.33 |
Issuance of Common Stock | 19.23 | - | 2.17 | 12.45 | 12.19 | 19.59 |
Other Financing Activities | - | - | 0 | - | - | - |
Financing Cash Flow | 27.83 | 8.64 | 6.12 | 12.12 | 11.83 | 19.26 |
Net Cash Flow | 13.07 | -5.07 | 3.87 | -5.16 | -8.37 | 2.63 |
Free Cash Flow | -6.5 | -6.53 | -7.03 | -16.41 | -19.65 | -15.84 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -39.81% | -44.87% | -101.27% | -165.16% | -194.31% | -179.68% |
Free Cash Flow Per Share | -1.15 | -1.40 | -1.66 | -9.48 | -28.74 | -27.94 |
Levered Free Cash Flow | -5.17 | -3.79 | 5.51 | -10.61 | -13.86 | -11.42 |
Unlevered Free Cash Flow | -4.67 | -3.35 | 5.56 | -10.56 | -13.78 | -11.33 |
Change in Working Capital | 1.48 | 0.73 | -0.22 | 1.44 | -0.71 | -2.04 |